查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405846

原位杂合反应市场规模、份额、趋势分析报告：按技术、按探针类型、按产品类型、按应用、按最终用途、按地区、细分市场预测，2024-2030 年

In Situ Hybridization Market Size, Share & Trends Analysis Report By Technology, By Probe Type, By Product, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

原位杂合反应市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计到2030年，全球原位杂合反应市场规模将达到25.5亿美元，预测期内复合年增长率为7.2%。

原位杂合反应（ISH）广泛应用于诊断研究和临床应用。 ISH 是研究人员中流行的方法，因为它有助于确定特定核酸的分布及其与目标基因蛋白产物的关係。因此，ISH的应用范围正在加速扩大，引发进一步的研究。

随着人们对 ISH 技术及其用途的认识不断提高，研究人员正在将其用于各种应用。例如，MultiplexDX的执行长在接受Elsevier采访时表示，FISH技术可以为早期药物开发和个体化治疗贡献突破性资讯。已开发国家意识的提高意味着更多的人选择个体化治疗，从而推动市场需求。

此外，新兴经济体保险报销系统的可用性正在增加对此诊断的需求。随着最近保险覆盖率的扩大，大多数人现在可以获得治疗，并且需求持续增加。例如，在美国，医疗保险是最大的市场参与者，为 65 岁及以上的老年人提供护理，无论收入或病历如何。

由于COVID-19大流行，需求方对ISH市场产生了积极影响，因为各种研究人员在COVID-19感染细胞上采用了ISH技术。 2020 年 7 月发表的一项研究使用 ISH 测定和 RNA 探针检查了来自 COVID-19 感染患者的 8 个尸检肺、10 个切片检查和 1 个胎盘。

ISH 在所有八个肺部和胎盘中均显示出阳性 COVID-19 结果，但在肾臟样本中未显示阳性结果。该测定代表了一种用于检测组织样本中病毒的灵敏且特异性的技术。同样，Advanced Cell Diagnostics, Inc. 推出了 RNAscope 技术来支援 COVID-19 研究。

公司不断采取的策略性倡议预计将推动 ISH 市场的成长。主要企业正在向市场推出新产品以增强其产品组合。例如，2021年3月，F. Hoffmann-La Roche推出了DISCOVERY Green HRP显色检测套件，扩展了原位杂合反应和免疫组化的多重检测能力。

另一方面，分子诊断提供准确有效的结果，是诊断领域的重要应用。然而，FISH 检测的高製造成本以及维护用于 FISH 成像的专业组装厂和设备所需的高资本可能会限制产生收入。

原位杂合反应市场报告亮点

  • 从技术面来看，CISH 产业预计在预测期内将以最快的成长率扩张。 CISH使用的试剂更加稳定，因此样本可以保存更长时间并进行多次测试。
  • 根据探针，DNA 片段预计将在预测期内表现出最快的成长率。这是因为与染色体异常相关的疾病（例如遗传异常和癌症）的发生率正在增加。
  • 按产品划分，2024年至2030年服务业预计将以最快的复合年增长率成长。增加外包以确保品质标准和改善业务功能有助于实现良好的成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场趋势及展望
  • 市场动态
    • 目标疾病盛行率上升
    • 体外诊断领域的技术进展
    • 加大体外诊断研发投入
  • 市场抑制因素分析
    • ISH费用高
    • 法规结构不明确
  • 2023 年普及与成长前景图
  • 营商环境分析
    • SWOT 分析；按因素（政治/法律、经济/技术）
    • 波特五力分析

第四章科技业务分析

  • 原位杂合反应市场：产品类型变异分析
  • FISH
    • 鱼类市场，2018-2030
  • CISH
    • CISH 市场，2018-2030

第五章 探索业务分析

  • 原位杂合反应市场：位点变异分析
  • DNA
    • DNA 市场，2018-2030
  • RNA
    • RNA市场，2018-2030

第六章 产品经营分析

  • 原位杂合反应市场：位点变异分析
  • 装置
    • 2018-2030年设备市场
  • 耗材及配件
    • 消耗品及配件市场，2018-2030
  • 软体
    • 软体市场，2018-2030
  • 服务
    • 服务市场，2018-2030

第七章 应用业务分析

  • 原位杂合反应市场：产品类型变异分析
  • 癌症
    • 癌症市场，2018-2030
  • 细胞遗传学
    • 细胞遗传学市场，2018-2030
  • 发育生物学
    • 发育生物学市场，2018-2030
  • 感染疾病
    • 感染疾病市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第 8 章最终用途业务分析

  • 原位杂合反应市场：最终用途变化分析
  • 医院和诊断实验室
    • 医院和诊断实验室市场，2018-2030
  • CRO
    • CRO市场，2018-2030
  • 学术/研究机构
    • 学术和研究机构市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第九章区域业务分析

  • 2023 年及 2030 年原位杂合反应市场占有率（按地区）
  • 北美洲
    • SWOT分析
    • 北美原位杂合反应市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • SWOT分析
    • 欧洲原位杂合反应市场，2018-2030
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • SWOT分析
    • 亚太原位杂合反应市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • SWOT分析
    • 拉丁美洲原位杂合反应市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • SWOT分析
    • 中东和非洲原位杂合反应市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第10章竞争形势

  • 公司分类
  • 策略规划
    • 新产品发布
    • 合伙
    • 获得
    • 合作
    • 资金筹措
  • 2023年主要企业市场占有率分析
  • 企业热力图分析
  • 公司简介
    • PerkinElmer, Inc.
    • Thermo Fisher Scientific, Inc.
    • BioView
    • Agilent Technologies, Inc.
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.
    • OXFORD GENE TECHNOLOGY IP LIMITED
    • LEICA BIOSYSTEMS NUSSLOCH GMBH（DANAHER CORPORATION）
    • NEOGENOMICS LABORATORIES, INC.
    • ADVANCED CELL DIAGNOSTICS, INC.
Product Code: GVR-2-68038-109-2

In Situ Hybridization Market Growth & Trends:

The global in situ hybridization market size is expected to reach USD 2.55 billion by 2030, registering a CAGR of 7.2% during the forecast period, according to a new report by Grand View Research, Inc. Situ Hybridization (ISH) is extensively utilized for research and clinical applications of diagnostics. ISH is a popular approach among researchers as it aids in determining the relationship between the distribution of specific nucleic acids and the target gene protein products. Hence, expanding the scope of ISH in applications is accelerating and leading to further research.

The increasing awareness about ISH techniques and their usage encourages researchers to employ the techniques for various applications. For instance, the CEO of MultiplexDX stated in an interview with Elsevier that FISH technology can contribute breakthrough information for early drug development and personalized treatment. A growing number of people in developed countries are opting for personalized treatment owing to an increase in awareness, thus boosting market demand.

Furthermore, reimbursement schemes being made available in developed economies have led to an increase in demand for this diagnosis. The demand continues to increase as the majority of the public can now afford it due to the recent expansion through insurance coverage. For instance, Medicare is the largest market player in the U.S., which provides care for those aged 65 years and above, irrespective of their income and medical history.

Owing to the COVID-19 pandemic, the demand side showcased a positive impact on the ISH market as various researchers employed the technique on COVID-19-infected cells. Research published in July 2020, considered 8 autopsy lungs, 10 kidney biopsies, and 1 placenta from COVID-19-infected patients with ISH assay and RNA probes.

COVID-19 positive results showed in all 8 lungs and the placenta by ISH, but not in the kidney samples. The assay showcases a sensitive and specific technique for detecting the virus from tissue samples. Similarly, Advanced Cell Diagnostics, Inc., introduced RNAscope technology to support COVID-19 research.

The growing strategic initiatives by the companies are anticipated to boost the ISH market growth. Key players are introducing novel products in the market to strengthen their portfolios. For instance, in March 2021, F. Hoffmann-La Roche launched DISCOVERY Green HRP chromogen detection kit to expand the multiplexing capability of in situ hybridization and immunohistochemistry.

On the other hand, molecular diagnostics renders accurate & effective results and has indispensable applications in the field of diagnosis. However, the high manufacturing cost of FISH assays and the high amount of capital required for specialized assembly plants & maintenance of instruments used in FISH imaging are likely to limit revenue generation.

In Situ Hybridization Market Report Highlights:

  • By technology, the CISH segment is projected to expand at the fastest growth rate during the forecast period. Since the reagents used in CISH are more stable, the sample can be stored for a longer duration and can be examined multiple times
  • By probe, the DNA segment is anticipated to have the fastest growth rate during the forecast period. Owing to the increasing incidence of diseases associated with chromosomal aberrations, such as genetic abnormalities and cancer
  • By product, the services segment is anticipated to have the fastest-growing CAGR between 2024 to 2030. Increasing outsourcing to ensure high adherence to quality standards and improve operational functionalities contributes to the lucrative growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Rising Prevalence of Target Disorders
    • 3.4.2. Technological Advancement In the Field of In Vitro Diagnostics
    • 3.4.3. Increasing R&D Investments In In Vitro Diagnostics
  • 3.5. Market Restraint Analysis
    • 3.5.1. High Cost of ISH
    • 3.5.2. Presence of An Ambiguous Regulatory Framework
  • 3.6. Penetration and Growth Prospect Mapping 2023
  • 3.7. Business Environment Analysis
    • 3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.7.2. Porter's Five Forces Analysis

Chapter 4. Technology Business Analysis

  • 4.1. In Situ Hybridization Market: Product Type Movement Analysis
  • 4.2. FISH
    • 4.2.1. FISH Market, 2018 - 2030 (USD Million)
  • 4.3. CISH
    • 4.3.1. CISH Market, 2018 - 2030 (USD Million)

Chapter 5. Probe Business Analysis

  • 5.1. In Situ Hybridization Market: Site Movement Analysis
  • 5.2. DNA
    • 5.2.1. DNA Market, 2018 - 2030 (USD Million)
  • 5.3. RNA
    • 5.3.1. RNA Market, 2018 - 2030 (USD Million)

Chapter 6. Product Business Analysis

  • 6.1. In Situ Hybridization Market: Site Movement Analysis
  • 6.2. Instruments
    • 6.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 6.3. Consumables & Accessories
    • 6.3.1. Consumables & Accessories Market, 2018 - 2030 (USD Million)
  • 6.4. Software
    • 6.4.1. Software Market, 2018 - 2030 (USD Million)
  • 6.5. Services
    • 6.5.1. Services Market, 2018 - 2030 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. In Situ Hybridization Market: Product Type Movement Analysis
  • 7.2. Cancer
    • 7.2.1. Cancer Market, 2018 - 2030 (USD Million)
  • 7.3. Cytogenetics
    • 7.3.1. Cytogenetics Market, 2018 - 2030 (USD Million)
  • 7.4. Developmental Biology
    • 7.4.1. Developmental Biology Market, 2018 - 2030 (USD Million)
  • 7.5. Infectious Diseases
    • 7.5.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. End-use Business Analysis

  • 8.1. In Situ Hybridization Market: End-use Movement Analysis
  • 8.2. Hospitals & Diagnostic Laboratories
    • 8.2.1. Hospitals & Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
  • 8.3. CROs
    • 8.3.1. CROs Market, 2018 - 2030 (USD Million)
  • 8.4. Academic & Research Institutes
    • 8.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 8.5. Others
    • 8.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. In Situ Hybridization Market Share By Region, 2023 & 2030
  • 9.2. North America
    • 9.2.1. SWOT Analysis
    • 9.2.2. North America In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.2.3. U.S.
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Target Disease Scenario
      • 9.2.3.3. Competitive Scenario
      • 9.2.3.4. Regulatory Framework
      • 9.2.3.5. Reimbursement Scenario
      • 9.2.3.6. U.S. In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.2.4. Canada
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Target Disease Scenario
      • 9.2.4.3. Competitive Scenario
      • 9.2.4.4. Regulatory Framework
      • 9.2.4.5. Reimbursement Scenario
      • 9.2.4.6. Canada In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. SWOT Analysis
    • 9.3.2. Europe In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Scenario
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Reimbursement Scenario
      • 9.3.3.6. Germany In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.3.4. UK
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Scenario
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Reimbursement Scenario
      • 9.3.4.6. UK In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.3.5. France
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Target Disease Scenario
      • 9.3.5.3. Competitive Scenario
      • 9.3.5.4. Regulatory Framework
      • 9.3.5.5. Reimbursement Scenario
      • 9.3.5.6. France In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.3.6. Italy
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Target Disease Scenario
      • 9.3.6.3. Competitive Scenario
      • 9.3.6.4. Regulatory Framework
      • 9.3.6.5. Reimbursement Scenario
      • 9.3.6.6. Italy In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.3.7. Spain
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Target Disease Scenario
      • 9.3.7.3. Competitive Scenario
      • 9.3.7.4. Regulatory Framework
      • 9.3.7.5. Reimbursement Scenario
      • 9.3.7.6. Spain In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.3.8. Denmark
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Target Disease Scenario
      • 9.3.8.3. Competitive Scenario
      • 9.3.8.4. Regulatory Framework
      • 9.3.8.5. Reimbursement Scenario
      • 9.3.8.6. Denmark In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.3.9. Sweden
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Target Disease Scenario
      • 9.3.9.3. Competitive Scenario
      • 9.3.9.4. Regulatory Framework
      • 9.3.9.5. Reimbursement Scenario
      • 9.3.9.6. Sweden In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.3.10. Norway
      • 9.3.10.1. Key Country Dynamics
      • 9.3.10.2. Target Disease Scenario
      • 9.3.10.3. Competitive Scenario
      • 9.3.10.4. Regulatory Framework
      • 9.3.10.5. Reimbursement Scenario
      • 9.3.10.6. Norway In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. SWOT Analysis
    • 9.4.2. Asia Pacific In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.4.3. Japan
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Scenario
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Reimbursement Scenario
      • 9.4.3.6. Japan In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.4.4. China
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Scenario
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. Reimbursement Scenario
      • 9.4.4.6. China In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.4.5. India
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Scenario
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Reimbursement Scenario
      • 9.4.5.6. India In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Scenario
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Reimbursement Scenario
      • 9.4.6.6. South Korea In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.4.7. Australia
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Scenario
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Reimbursement Scenario
      • 9.4.7.6. Australia In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.4.8. Thailand
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Target Disease Scenario
      • 9.4.8.3. Competitive Scenario
      • 9.4.8.4. Regulatory Framework
      • 9.4.8.5. Reimbursement Scenario
      • 9.4.8.6. Thailand In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. SWOT Analysis
    • 9.5.2. Latin America In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.5.3. Brazil
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Scenario
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. Reimbursement Scenario
      • 9.5.3.6. Brazil In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.5.4. Mexico
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Scenario
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. Regulatory Framework
      • 9.5.4.5. Reimbursement Scenario
      • 9.5.4.6. Mexico In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.5.5. Argentina
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Target Disease Scenario
      • 9.5.5.3. Competitive Scenario
      • 9.5.5.4. Regulatory Framework
      • 9.5.5.5. Reimbursement Scenario
      • 9.5.5.6. Argentina In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.6. MEA
    • 9.6.1. SWOT Analysis
    • 9.6.2. MEA In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.6.3. South Africa
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Scenario
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Reimbursement Scenario
      • 9.6.3.6. South Africa In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.6.4. Saudi Arabia
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Target Disease Scenario
      • 9.6.4.3. Competitive Scenario
      • 9.6.4.4. Regulatory Framework
      • 9.6.4.5. Reimbursement Scenario
      • 9.6.4.6. Saudi Arabia In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.6.5. UAE
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Target Disease Scenario
      • 9.6.5.3. Competitive Scenario
      • 9.6.5.4. Regulatory Framework
      • 9.6.5.5. Reimbursement Scenario
      • 9.6.5.6. UAE In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.6.6. Kuwait
      • 9.6.6.1. Key Country Dynamics
      • 9.6.6.2. Target Disease Scenario
      • 9.6.6.3. Competitive Scenario
      • 9.6.6.4. Regulatory Framework
      • 9.6.6.5. Reimbursement Scenario
      • 9.6.6.6. Kuwait In Situ Hybridization Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Strategy Mapping
    • 10.2.1. New Product Launch
    • 10.2.2. Partnerships
    • 10.2.3. Acquisition
    • 10.2.4. Collaboration
    • 10.2.5. Funding
  • 10.3. Key Company Market Share Analysis, 2023
  • 10.4. Company Heat Map Analysis
  • 10.5. Company Profiles
    • 10.5.1. . PerkinElmer, Inc.
      • 10.5.1.1. Company Overview
      • 10.5.1.2. Financial Performance
      • 10.5.1.3. Product Benchmarking
      • 10.5.1.4. Strategic Initiatives
    • 10.5.2. Thermo Fisher Scientific, Inc.
      • 10.5.2.1. Company Overview
      • 10.5.2.2. Financial Performance
      • 10.5.2.3. Product Benchmarking
      • 10.5.2.4. Strategic Initiatives
    • 10.5.3. BioView
      • 10.5.3.1. Company Overview
      • 10.5.3.2. Financial Performance
      • 10.5.3.3. Product Benchmarking
      • 10.5.3.4. Strategic Initiatives
    • 10.5.4. Agilent Technologies, Inc.
      • 10.5.4.1. Company Overview
      • 10.5.4.2. Financial Performance
      • 10.5.4.3. Product Benchmarking
      • 10.5.4.4. Strategic Initiatives
    • 10.5.5. Merck KGaA
      • 10.5.5.1. Company Overview
      • 10.5.5.2. Financial Performance
      • 10.5.5.3. Product Benchmarking
      • 10.5.5.4. Strategic Initiatives
    • 10.5.6. Bio-Rad Laboratories, Inc.
      • 10.5.6.1. Company Overview
      • 10.5.6.2. Financial Performance
      • 10.5.6.3. Product Benchmarking
      • 10.5.6.4. Strategic Initiatives
    • 10.5.7. OXFORD GENE TECHNOLOGY IP LIMITED
      • 10.5.7.1. Financial Performance
      • 10.5.7.2. Product Benchmarking
      • 10.5.7.3. Strategic Initiatives
    • 10.5.8. LEICA BIOSYSTEMS NUSSLOCH GMBH (DANAHER CORPORATION)
      • 10.5.8.1. Company Overview
      • 10.5.8.2. Financial Performance
      • 10.5.8.3. Product Benchmarking
      • 10.5.8.4. Strategic Initiatives
    • 10.5.9. NEOGENOMICS LABORATORIES, INC.
      • 10.5.9.1. Financial Performance
      • 10.5.9.2. Product Benchmarking
      • 10.5.9.3. Strategic Initiatives
    • 10.5.10. ADVANCED CELL DIAGNOSTICS, INC.
      • 10.5.10.1. Company Overview
      • 10.5.10.2. Financial Performance
      • 10.5.10.3. Product Benchmarking
      • 10.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 4 Global In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 5 Global In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 6 Global In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 7 Global In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 8 Global In Situ Hybridization Market, by Region, 2018 - 2030 (USD Million)
  • Table 9 North America In Situ Hybridization Market, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 11 North America In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 12 North America In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 13 North America In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 14 North America In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 15 U.S. In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 17 U.S. In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 18 U.S. In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 U.S. In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Canada In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 21 Canada In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 22 Canada In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Canada In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 Canada In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Europe In Situ Hybridization Market, by Country, 2018 - 2030 (USD Million)
  • Table 26 Europe In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 27 Europe In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 28 Europe In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 29 Europe In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 30 Europe In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 31 Germany In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 32 Germany In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 Germany In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 34 Germany In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 35 Germany In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 36 UK In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 UK In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 38 UK In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 UK In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 UK In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 41 France In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 42 France In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 43 France In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 44 France In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 45 France In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 46 Italy In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 47 Italy In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 48 Italy In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 49 Italy In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 50 Italy In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 51 Spain In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 52 Spain In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 53 Spain In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 54 Spain In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 55 Spain In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 56 Sweden In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 Sweden In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 58 Sweden In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 59 Sweden In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 60 Sweden In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Denmark In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 62 Denmark In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 63 Denmark In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Denmark In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Denmark In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 66 Norway In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 67 Norway In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 68 Norway In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 69 Norway In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 70 Norway In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific In Situ Hybridization Market, by Country, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 77 China In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 China In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 79 China In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 80 China In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 China In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 82 Japan In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 83 Japan In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 84 Japan In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 85 Japan In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 86 Japan In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 87 India In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 88 India In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 89 Indian Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 90 India In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 91 Indian Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 92 South Korea In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 93 South Korea In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 94 South Korean Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 95 South Korea In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 96 South Korean Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 97 Australia In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 98 Australia In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 99 Australia In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 100 Australia In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 101 Australia In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 102 Thailand In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 103 Thailand In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 104 Thailand In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 105 Thailand In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 106 Thailand In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 107 Latin America In Situ Hybridization Market, by Country, 2018 - 2030 (USD Million)
  • Table 108 Latin America In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 109 Latin America In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 110 Latin America In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 111 Latin America In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 112 Latin America In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 113 Brazil In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 114 Brazil In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 115 Brazil in Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 116 Brazil In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 117 Brazil In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 118 Mexico In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 119 Mexico In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 120 Mexico In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 121 Mexico In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 122 Mexico In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 123 Argentina In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 124 Argentina In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 125 Argentina In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 126 Argentina In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 127 Argentina In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa In Situ Hybridization Market, by Country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 134 South Africa In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 135 South Africa In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 136 South Africa In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 137 South Africa In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 138 South Africa In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 144 UAE In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 145 UAE In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 146 UAE In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 147 UAE In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 148 UAE In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 150 Kuwait In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 151 Kuwait In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 152 Kuwait In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 153 Kuwait In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million) 

List of Figures

  • Fig. 1 In situ hybridization market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation and validation
  • Fig. 9 Commodity flow approach
  • Fig. 10 Market snapshot (USD Million)
  • Fig. 11 Segment snapshot (technology, probe & end-use)
  • Fig. 12 Segment snapshot (product & application)
  • Fig. 13 Competitive snapshot
  • Fig. 14 Market trends & outlook
  • Fig. 15 Estimated number of new cases from 2020 to 2040, both sexes, age [0-85+], globally.
  • Fig. 16 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 In situ hybridization market: Technology type outlook key takeaways (USD Million)
  • Fig. 19 In situ hybridization market: Technology type movement analysis
  • Fig. 20 In situ hybridization market for FISH, 2018 - 2030 (USD Million)
  • Fig. 21 In situ hybridization market for CISH, 2018 - 2030 (USD Million)
  • Fig. 22 In situ hybridization market: Probe outlook key takeaways (USD Million)
  • Fig. 23 In situ hybridization market: Probe movement analysis
  • Fig. 24 In situ hybridization market for DNA, 2018 - 2030 (USD Million)
  • Fig. 25 In situ hybridization market for RNA, 2018 - 2030 (USD Million)
  • Fig. 26 In situ hybridization market: End-use outlook key takeaways (USD Million)
  • Fig. 27 In situ hybridization market: End-use type movement analysis
  • Fig. 28 In situ hybridization market for hospital & diagnostics laboratories, 2018 - 2030 (USD Million)
  • Fig. 29 In situ hybridization market for CROs, 2018 - 2030 (USD Million)
  • Fig. 30 In situ hybridization market for academic institutes, 2018 - 2030 (USD Million)
  • Fig. 31 In situ hybridization market for other end-use, 2018 - 2030 (USD Million)
  • Fig. 32 In situ hybridization market: Product outlook and key takeaways
  • Fig. 33 In situ hybridization market: Product movement analysis
  • Fig. 34 In situ hybridization market instruments, 2018 - 2030 (USD Million)
  • Fig. 35 In situ hybridization kits and probes market, 2018 - 2030 (USD Million)
  • Fig. 36 In situ hybridization software market, 2018 - 2030 (USD Million)
  • Fig. 37 In situ hybridization services market, 2018 - 2030 (USD Million)
  • Fig. 38 In situ hybridization market: Application outlook and key takeaways
  • Fig. 39 In situ hybridization market: Application movement analysis
  • Fig. 40 Cancer application for in situ hybridization market, 2018 - 2030 (USD Million)
  • Fig. 41 Cytogenetics application for in situ hybridization market, 2018 - 2030 (USD Million)
  • Fig. 42 Development biology application for in situ hybridization market, 2018 - 2030 (USD Million)
  • Fig. 43 Infectious diseases application for in situ hybridization market, 2018 - 2030 (USD Million)
  • Fig. 44 Other applications for in situ hybridization market, 2018 - 2030 (USD Million)
  • Fig. 45 In situ hybridization market revenue, by region, 2022 & 2030 (USD Million)
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 North America in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 U.S. in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Cancer Incidence, 2018 - 2030
  • Fig. 51 Competitive scenario
  • Fig. 52 Key country dynamics
  • Fig. 53 Canada in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Cancer incidence, 2018 - 2030
  • Fig. 55 Competitive scenario
  • Fig. 56 Europe in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 UK in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Cancer incidence, 2018 - 2030
  • Fig. 60 Competitive scenario
  • Fig. 61 Key country dynamics
  • Fig. 62 Germany in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Cancer incidence, 2018 - 2030
  • Fig. 64 Competitive scenario
  • Fig. 65 Key country dynamics
  • Fig. 66 France in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Cancer incidence, 2018 - 2030
  • Fig. 68 Competitive scenario
  • Fig. 69 Key country dynamics
  • Fig. 70 Spain in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Cancer incidence, 2018 - 2030
  • Fig. 72 Competitive scenario
  • Fig. 73 Key country dynamics
  • Fig. 74 Italy in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Cancer incidence, 2018 - 2030
  • Fig. 76 Competitive scenario
  • Fig. 77 Key country dynamics
  • Fig. 78 Denmark in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Target disease prevalence
  • Fig. 80 Competitive scenario
  • Fig. 81 Regulatory framework
  • Fig. 82 Key country dynamics
  • Fig. 83 Sweden in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Five most common cancers in Sweden
  • Fig. 85 Competitive scenario
  • Fig. 86 Regulatory framework
  • Fig. 87 Key country dynamics
  • Fig. 88 Norway in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Number of new cancer cases in 2020, both sexes, all ages
  • Fig. 90 Competitive scenario
  • Fig. 91 Rest of Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Japan in situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Cancer incidence, 2018 to 2030
  • Fig. 96 Competitive scenario
  • Fig. 97 Key country dynamics
  • Fig. 98 China in situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 99 Cancer incidence, 2018 to 2030
  • Fig. 100 Competitive scenario
  • Fig. 101 Key country dynamics
  • Fig. 102 India in situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 103 Cancer incidence, 2018 to 2030
  • Fig. 104 Competitive scenario
  • Fig. 105 Key country dynamics
  • Fig. 106 Australia in situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 107 Cancer incidence, 2018 to 2030
  • Fig. 108 Competitive scenario
  • Fig. 109 Key country dynamics
  • Fig. 110 Thailand in situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 111 Cancer incidence, 2020 to 2030
  • Fig. 112 Competitive scenario
  • Fig. 113 Key country dynamics
  • Fig. 114 South Korea in situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 115 Cancer incidence 2018 to 2030
  • Fig. 116 Competitive scenario
  • Fig. 117 Rest of Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 118 Latin America in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 119 Key country dynamics
  • Fig. 120 Brazil in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 121 Estimated number of new cancer cases in Brazil
  • Fig. 122 Competitive scenario
  • Fig. 123 Key country dynamics
  • Fig. 124 Mexico in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 125 Estimated number of new cancer cases in Mexico
  • Fig. 126 Competitive scenario
  • Fig. 127 Key country dynamics
  • Fig. 128 Argentina in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 129 Estimated number of new cancer cases in Argentina
  • Fig. 130 Competitive scenario
  • Fig. 131 Rest of LATAM market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 132 MEA in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 133 Key country dynamics
  • Fig. 134 South Africa in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 135 Cancer prevalence-2018 - 2030
  • Fig. 136 Competitive scenario
  • Fig. 137 Key country dynamics
  • Fig. 138 Saudi Arabia in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 139 Cancer prevalence-2018 - 2030
  • Fig. 140 Competitive scenario
  • Fig. 141 Key country dynamics
  • Fig. 142 UAE in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 143 Cancer prevalence 2018 - 2030
  • Fig. 144 Competitive scenario
  • Fig. 145 Key country dynamics
  • Fig. 146 Kuwait in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 147 Target disease prevalence
  • Fig. 148 Competitive scenario
  • Fig. 149 Key payors in Kuwait
  • Fig. 150 Rest of MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 151 Market participant categorization
  • Fig. 152 In situ hybridization market share analysis, 2022
  • Fig. 153 Strategic framework
  • Fig. 154 Ansoff Matrix
  • Fig. 155 Competition categorization
  • Fig. 156 Company market position analysis (Diagnostics)
  • Fig. 157 Company market position analysis